Monahan Joseph
Officer at ACRS
- Sold, on record
- $2.1M
- Dollars the filings state
- Form 4 sales
- 11
- Latest Oct 23, 2023
- Form 144 notices
- 3
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ACRSAclaris Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ACRSPlan not statedFeb 15, 2023 2023
Sold 5,000 shares at $13.06 ($65k)
Monahan Joseph, Chief Scientific Officer
Sold 5.2% of holdings ($1.3M position)91,386 shares left0.4x usual sizeFiling
- 2 Form 4 sale ACRSUnusualMar 3, 2023 +16 days
Sold 30,837 shares at $12.51 ($386k)
Monahan Joseph, Chief Scientific Officer
Sold 17.3% of holdings ($2.2M position)147,724 shares left6.2x usual sizeFiling
- 3 Form 144 notice ACRSNoticeJun 20, 2023 +109 days
Filed to sell 6,000 shares ($61k)
Monahan Joseph, Officer
10b5-1 plan1.2x usual sizeFiling
- 4 Form 4 sale ACRSRoutineJun 20, 2023 same day
Sold 6,000 shares at $10.28 ($62k)
Monahan Joseph, Chief Scientific Officer
10b5-1 planSold 4.1% of holdings ($1.5M position)141,724 shares left1.2x usual sizeFollows a Form 144Filing
- 5 Form 144 notice ACRSNoticeAug 21, 2023 +62 days
Filed to sell 6,000 shares ($43k)
Monahan Joseph, Officer
10b5-1 plan1.1x usual sizeFiling
- 6 Form 4 sale ACRSRoutineAug 21, 2023 same day
Sold 6,000 shares at $7.32 ($44k)
Monahan Joseph, Chief Scientific Officer
10b5-1 planSold 4.2% of holdings ($1M position)135,724 shares left1.1x usual sizeFollows a Form 144Filing
- 7 Form 144 notice ACRSNoticeOct 23, 2023 +63 days
Filed to sell 6,000 shares ($32k)
Monahan Joseph, Officer
10b5-1 plan1x usual sizeFiling
- 8 Form 4 sale ACRSRoutineOct 23, 2023 same day
Sold 6,000 shares at $5.08 ($30k)
Monahan Joseph, Chief Scientific Officer
10b5-1 planSold 4.4% of holdings ($689k position)129,724 shares left1x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 23, 2023 | Oct 25, 2023 | ACRS | Chief Scientific Officer | Form 4 sale | 6,000 | $30k | 4.4% | Routine | SEC |
| Oct 23, 2023 | Oct 23, 2023 | ACRS | Officer | Form 144 notice | 6,000 | $32k | Notice | SEC | |
| Aug 21, 2023 | Aug 22, 2023 | ACRS | Chief Scientific Officer | Form 4 sale | 6,000 | $44k | 4.2% | Routine | SEC |
| Aug 21, 2023 | Aug 21, 2023 | ACRS | Officer | Form 144 notice | 6,000 | $43k | Notice | SEC | |
| Jun 20, 2023 | Jun 22, 2023 | ACRS | Chief Scientific Officer | Form 4 sale | 6,000 | $62k | 4.1% | Routine | SEC |
| Jun 20, 2023 | Jun 20, 2023 | ACRS | Officer | Form 144 notice | 6,000 | $61k | Notice | SEC | |
| Mar 3, 2023 | Mar 3, 2023 | ACRS | Chief Scientific Officer | Form 4 sale | 30,837 | $386k | 17.3% | Unusual | SEC |
| Feb 15, 2023 | Feb 17, 2023 | ACRS | Chief Scientific Officer | Form 4 sale | 5,000 | $65k | 5.2% | Plan not stated | SEC |
| Dec 15, 2022 | Dec 16, 2022 | ACRS | Chief Scientific Officer | Form 4 sale | 5,000 | $79k | 4.9% | Plan not stated | SEC |
| Oct 17, 2022 | Oct 19, 2022 | ACRS | Chief Scientific Officer | Form 4 sale | 5,000 | $80k | 4.7% | Plan not stated | SEC |
| Apr 18, 2022 | Apr 20, 2022 | ACRS | Chief Scientific Officer | Form 4 sale | 30,000 | $488k | 22.0% | Plan not stated | SEC |
| Mar 10, 2022 | Mar 14, 2022 | ACRS | Chief Scientific Officer | Form 4 sale | 27,165 | $427k | 16.6% | Plan not stated | SEC |
| Feb 9, 2022 | Feb 11, 2022 | ACRS | Chief Scientific Officer | Form 4 sale | 383 | $5k | 0.4% | Plan not stated | SEC |
| Jun 2, 2021 | Jun 2, 2021 | ACRS | Chief Scientific Officer | Form 4 sale | 21,790 | $471k | 20.3% | Plan not stated | SEC |